Business
Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products
-- Multi-Product Distribution Agreement Marks Continued Commercial Momentum in Europe --ATLANTA, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced today a new strategic distribution partnership with OR Consulting to support the commercial launch of its product portfolio in Switzerland. The agreement includes FemBloc Permanent Birth
About this update from Femasys Inc.
[{"type":"image","alt":"Femasys Inc.","displaySize":"","headline":null,"caption":"Femasys Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":122,"url":"https://media.zenfs.com/en/globenewswire.com/301b83514d43baad2f5211eaa290a825"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/GL8WCCgrHOHP9r8Vdi7XpQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE3MTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/301b83514d43baad2f5211eaa290a825","width":300,"height":122}},"lazy":false},{"type":"text","content":"-- Multi-Product Distribution Agreement Marks Continued Commercial Momentum in Europe --","length":88,"tagName":"p"},{"type":"text","content":"ATLANTA, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced today a new strategic distribution partnership with OR Consulting to support the commercial launch of its product portfolio in Switzerland. The agreement includes FemBloc Permanent Birth Control, FemaSeed Intratubal Insemination, and additional Femasys fertility and women’s diagnostic health products. Together with the Company’s recent market entry in Spain and the ongoing commercial launch in France, this partnership represents continued execution of Femasys’ European expansion strategy and broadens access to its innovative technologies through experienced regional partners.","length":808,"tagName":"p"},{"type":"text","content":"“Expanding into Switzerland with OR Consulting further strengthens our European commercial platform and reflects our disciplined approach to building a multi-country footprint through experienced regional partners,” said Kathy Lee-Sepsick, Chief Executive Officer and Founder of Femasys Inc. “With FemBloc launches underway in Spain and France, and Switzerland providing access to our full portfolio, including FemaSeed for fertility, we are advancing availability across Europe while executing our long-term global growth strategy.”","length":533,"tagName":"p"},{"type":"text","content":"“Switzerland is an important and sophisticated market for women’s health innovation,” said Christophe Sarzier, Chief Executive Officer of OR Consulting. “We are excited to support the introduction of FemBloc alongside Femasys’ broader fertility and women’s h...